Latest News
Novavax makes one million doses of protein-based COVID-19 vaccine available in UK
27 September 2022 - Biotechnology company Novavax Inc (Nasdaq:NVAX) announced on Tuesday that an initial one million doses of its COVID-19 vaccine Nuvaxovid are now available for use in the UK.Nuvaxovid is the first protein-based COVID-19 vaccine to ...
Sanofi granted non-exclusive license to Scribe Therapeutics' genome editing technology
27 September 2022 - Molecular engineering company Scribe Therapeutics Inc announced on Tuesday a new research collaboration with French healthcare company Sanofi SA (Euronext Paris: SAN) (NASDAQ: SNY).Under the agreement Sanofi will use Scribe's...
Ocular Therapeutix reports interim results of US Phase 1 clinical trial of OTX-TKI for wet AMD
27 September 2022 - Biopharmaceutical Ocular Therapeutix Inc (NASDAQ:OCUL), a provider of therapies for diseases and conditions of the eye, announced on Tuesday that interim 7-month data from its US Phase 1 clinical trial evaluating OTX-TKI, its axit...
WuXi STA opens first high potency oral drug product manufacturing facility at Wuxi city campus
27 September 2022 - WuXi STA, a China-based global Contract Research, Development, and Manufacturing Organisation (CRDMO), announced on Monday that it has opened its first high potency (HP) oral drug product manufacturing facility at its Wuxi city ca...
Corbus Pharmaceuticals Holdings, Inc names new director
27 September 2022 - Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a US-based immunology company, announced on Monday that it has named Anne Altmeyer, PhD, MBA, MPH as its new director.Presently, Dr Altmeyer is the president and CEO of TigaTx,...